{"id":"W4386052329","doi":"10.1097/01.hs9.0000970512.51896.93","title":"P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Carfilzomib; Medicine; Tolerability; Internal medicine; Multiple myeloma; Lenalidomide; Dexamethasone; Adverse effect; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00146174,0.001277663,0.00143774,0.0004102808,0.0003264965,0.0009776889,0.0008390329,0.001517926,0.005880115],"category_scores_gemma":[0.0005846682,0.0004258038,0.001077115,0.0003274038,0.0004907968,0.000815371,0.0003213008,0.002603906,0.001346659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006727255,"about_ca_system_score_gemma":0.001059422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009875933,"about_ca_topic_score_gemma":0.003121127,"domain_scores_codex":[0.9996862,0.0001313744,0.00001595222,0.00004113265,0.00003276886,0.00009256613],"domain_scores_gemma":[0.9995696,0.00005606835,0.0001069265,0.00002625434,0.00001892559,0.0002221895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7326664,0.04383188,0.004511614,0.001476128,0.001550046,0.000650086,0.0002247767,0.002082505,0.02150345,0.000313237,0.01623117,0.1749588],"study_design_scores_gemma":[0.714058,0.26342,0.01247742,0.0001135616,0.0005545354,0.0005532473,0.00004203097,0.000987775,0.002243353,0.0002524722,0.005268179,0.00002950966],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9682353,0.01276479,0.0008144303,0.001962945,0.0005295929,0.00433276,0.004380482,0.0004167639,0.006563038],"genre_scores_gemma":[0.9693058,0.007040761,0.00218772,0.002699665,0.0006471307,0.00422015,0.006543322,0.00006137015,0.007294137],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005880115,"threshold_uncertainty_score":0.01967096,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1046925907281177,"score_gpt":0.4121982522362392,"score_spread":0.3075056615081216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}